Taiwania Capital Management Corporation

Taiwania Capital is a venture capital firm that was founded in August 2017 by the National Development Fund of the Executive Yuan of Taiwan and private enterprises. Our mission is to establish a partnership with companies worldwide and boost Taiwan’s economic growth. We focus on financial returns but more than that, by linking technology and capital, we aspire to create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation.

Huang, Michael

Managing Partner

David Weng

CEO

Cheng Wu

General Partner

46 past transactions

Ethernovia

Series A in 2023
Developing an Ethernet system sophisticated enough to process the bandwidth demands of the future requires expert integration at multiple levels. By unifying the vehicle network, the Ethernovia system has the power to dramatically alter how cars are designed and built.

Light Field Lab

Series B in 2023
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Cognito Health

Convertible Note in 2022
Cognito Health improves the healthcare environment by increasing value for patients and healthcare systems. They continuously monitor patients using predictive algorithms to inform their staff about potential bed exits and repositioning needs.

Fractyl Health

Series F in 2022
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers. Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.

Avesha

Funding Round in 2022
Avesha is a technology platform that enables application workloads to disaggregate across cloud, multi-cloud, and edge locations. Enterprises can improve business outcomes by enabling more automation, real-time use cases, and high performance/low latency applications by distributing data and application logic closer to the end-users. The Avesha SNAP (Smart Network Application Platform) creates a virtual overlay on any network underlay. The company was founded in 2019 and is headquartered in Burlington, Massachusetts.

FIGUR8

Convertible Note in 2022
FIGUR8 is an MIT spin-off company, creating the most advanced wearable musculoskeletal (MSK) technology on the market. The solution combines Smart Biosensors, Intuitive Software and AI to analyze and advance musculoskeletal health. Our solution accurately pinpoints the source of MSK pathology and provides essential data to enhance patient-centric recovery. Value is recorded across the entire episode of care, from injury through full recovery. FIGUR8 technology aids in significantly reducing the cost of care, improving access, and empowering patients to take control of their personal MSK health.

Verana Networks

Series B in 2022
Verana Networks develops an innovative 5G Radio Access Network solution for service providers that have licensed millimeter wave (mmWave) spectrum. The company focuses on enabling 5G in mmWave spectrum because that is where the largest amount of new spectrum is. For 5G to succeed, it must deliver a 10X-50X increase in speed and capacity. Blazing fast speed and an increase in capacity enable new applications, these new applications create incremental revenue, and incremental revenue is essential to support the business case for 5G.

Nanolive

Series C in 2022
Nanolive SA was incorporated in November 2013 at the EPFL Innovation Park in Lausanne, Switzerland, by Dr. Yann Cotte (CEO) and Dr. Fatih Toy (scientific advisor), following the completion of their respective PhD theses at the EPFL Microsystems laboratory of Prof. Christian Depeursinge (Head of Scientific Advisory Board).

Light Field Lab

Funding Round in 2022
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Canner

Seed Round in 2022
Canner is a provider of data management solutions that helps businesses handle the complexities of data and business context. The company has created a universal semantic layer powered by AI, which harmonizes the schema, structure, relationship, and metadata between data and semantic context through an open standard semantic definition and architecture. This innovative approach fundamentally changes how businesses interact with their data using advanced AI technologies. Canner currently offers flagship products such as Canner Enterprise, an enterprise-grade semantic layer, and WrenAI, an open-source AI agent and semantic framework.

Windgap Medical

Series B in 2022
WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. The company develops auto-injectors that are filled with heat-stable epinephrine that enable physicians to inject it into a patient suffering from anaphylaxis due to an acute allergy attack. The company was established in 2011 and is headquartered in Somerville, Massachusetts.
Pavilion Data Systems is redefining storage to put real-time performance at scale within reach of all. Pavilion provides unmatched storage performance and density, without the cost and complexity of legacy all flash arrays (AFAs). Pavilion provides consistent, predictable performance across the fabric with ultra-low latency and linear scalability. Pavilion has disrupted the enterprise storage landscape with its innovative architecture and software and is pulling the industry into a new category of storage appliances: Hyperparallel Flash Arrays. Hyperparallel Flash Arrays utilize multiple controllers within a single system and leverage the parallelism of flash to go beyond the limitations of legacy, dual controller AFAs, delivering breakthrough performance and value. Pavilion is the leader of this new “Third wave” of storage with the largest deployments and most deployments because the customer need for ever-increasing data throughput continues to expand. Pavilion Data Systems brings together experienced technology professionals with expertise in storage system architecture, network switch design, dense micro-server architectures, and solid-state storage technology to deliver a ground-breaking storage system design that is purpose-built to take advantage of memory-class media available both today and in the future.

Appaegis

Seed Round in 2021
Appaegis simplifies enterprise data access while enforcing strong zero-trust security for remote access. Its patent-pending solution protects data access and gives administrators full control over how enterprise data is used. The company was founded by security veterans with successful security track records.

LandingAI

Series A in 2021
LandingAI empowers customers to harness the business value of AI by providing enablement tools and transformation programs. One of the company’s core products is LandingLens, an end-to-end AI platform specifically designed for industrial customers to build, deploy and scale AI-powered visual inspection solutions. Founded by one of the most recognizable names in AI, Dr. Andrew Ng, (founding lead of the Google Brain team and former Chief Scientist at Baidu), and a world class team, LandingAI is uniquely positioned to help companies across the globe successfully move their AI projects from proof-of-concept to full-scale production. Additional information is available at: www.landing.ai.

Ethernovia

Series A in 2021
Developing an Ethernet system sophisticated enough to process the bandwidth demands of the future requires expert integration at multiple levels. By unifying the vehicle network, the Ethernovia system has the power to dramatically alter how cars are designed and built.
Elixiron Immunotherapeutics is driven by an international team with a shared vision to produce next-generation immunotherapies. This vision drives our mission to target rare and inflammatory disorders as well as cancer for indications that could substantially benefit from advances in immunotherapy approaches. We employ advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics derived from a proprietary human antibody domain phage display library and a single human B cell antibody cloning platform to develop innovative therapies. Our two lead pipeline candidates are in phase 1 clinical trials. EI-1071, a small molecule inhibitor of CSF-1R kinase activity, is being explored as a potential therapy for Alzheimer's disease as well as tenosynovial giant cell tumors, and a monoclonal antibody, EI-001 is being developed for the treatment of vitiligo and other immunological disorders.

AEye

Post in 2021
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Korea, and the United States.

SafeLiShare

Seed Round in 2021
SafeLiShare makes it easy and safe to unlock new business models based on the sensitive and private data and programs that you own and generate.

KDAN

Series B in 2021
KDAN specializes in AI-driven workflow and data solutions that enhance operational efficiency and organizational agility. The company offers a range of digital tools, including document management and e-signature services, to support business growth and decision-making.

FIGUR8

Series A in 2021
FIGUR8 is an MIT spin-off company, creating the most advanced wearable musculoskeletal (MSK) technology on the market. The solution combines Smart Biosensors, Intuitive Software and AI to analyze and advance musculoskeletal health. Our solution accurately pinpoints the source of MSK pathology and provides essential data to enhance patient-centric recovery. Value is recorded across the entire episode of care, from injury through full recovery. FIGUR8 technology aids in significantly reducing the cost of care, improving access, and empowering patients to take control of their personal MSK health.

ARRIS

Series C in 2021
ARRIS develops an additive molding technology for manufacturing 3D-aligned continuous fiber thermoplastic composite parts at scale. Its composites manufacturing technology combines continuously aligned fibers, electronics, and metallic components within topology-optimized structures.

Oculii

Series B in 2021
Oculii is creating a next-generation AI software platform for radars that’s exponentially higher resolution, longer range, more accurate, and less expensive than conventional solutions – increasing safety and reliability. The promise of autonomous vehicles depends on high-performance, all-weather, low-cost and scalable perception technology, and Oculii is bringing it to the world. Oculii's AI software amplifies the resolution of any radar platform, enabling high performance perception for the next generation of autonomous systems. Traditional phased array radars have been used for decades and follow a strict size for performance tradeoff - the larger the sensor aperture, the higher the angular resolution. Oculii’s Virtual Aperture Imaging radar technology fundamentally breaks this tradeoff - enabling its sensors to trade increased compute/processing for angular resolution enhancement with the same physical aperture. Leveraging this technique enables Oculii sensors to extract unprecedented accuracy, range, and 4D positioning information from commodity off the shelf low-cost radar elements, bringing high resolution radar imaging to the next frontier. Oculii is backed by some of the top investors and corporations from Silicon Valley, and is working with the leaders in Self Driving Vehicles, Robotics, and Drones - helping them deliver on an autonomous future with an advanced, robust, affordable perception platform.

Ubiik

Series A in 2021
Ubiik, an emerging leader in Advanced Metering Infrastructure (AMI) and private LTE (pLTE) solutions, employs its Weightless™ and cellular IoT LPWAN technologies. Founded in 2016, Ubiik started its IoT business by providing Weightless™ LPWAN, a high performance open standard communication protocol successful with Advanced Metering Infrastructure private deployments. Since its successful AMI project in 2018 which has expanded its product portfolio to a PaaS platform, Ubiik has become a vertical IoT solutions provider. It has since grown its connectivity offerings to include LTE technologies to cover the multi-modality of the IoT market, especially for applications with strong security requirements that can be met with 3GPP standards.

Suono Bio

Series A in 2021
Suono Bio is a biotechnology company enabling ultra-rapid delivery of novel therapeutics to the gastrointestinal tract. The company's mission is to harness its proprietary therapeutic platform to transform the treatment of difficult-to-treat diseases by enabling localized delivery of small molecules, biologics, nucleic acids, and gene therapies without the need for encapsulation.

Avesha

Seed Round in 2021
Avesha is a technology platform that enables application workloads to disaggregate across cloud, multi-cloud, and edge locations. Enterprises can improve business outcomes by enabling more automation, real-time use cases, and high performance/low latency applications by distributing data and application logic closer to the end-users. The Avesha SNAP (Smart Network Application Platform) creates a virtual overlay on any network underlay. The company was founded in 2019 and is headquartered in Burlington, Massachusetts.

Viracta Therapeutics

Series E in 2020
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphoma. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.

Ambiq Micro

Series F in 2020
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low-power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

Artilux Inc.

Series B in 2020
Ushering in an age of data-driven technology Artilux Connect Series provides complete IC solutions featuring high performance with competitive cost for various optical connectivity applications. Our product portfolios cover short range 10-40G consumer usages, to long range 100G data center links. We embed advanced optical and RF technology into every wire to enable seamless and instant data transfer in our living room or up in the cloud.

C4 Therapeutics

Series B in 2020
C4 is building on the knowledge with synthetic chemical compounds which it calls Degronimids. These compounds can be engineered and linked together to bind with many molecular targets that today’s drugs can’t bind with, Cohen said. The key insight, he said, is that the scientific founders have discovered a way to bind with select disease-causing proteins, and flag them as cellular trash, so that the ordinary proteasome garbage disposal system can get rid of them. Selecting the precise disease-related proteins to send to the trash is obviously critical, because any drug like this could cause serious side effects if it sent healthy proteins involved in normal cell processes to the trash. C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. Our Degronimid™ platform incorporates highly selective small molecule binders to target disease-causing proteins and facilitate their rapid destruction and clearance from the cell through the natural ubiquitin/proteasome system (UPS). Because of this distinctive mechanism, Degronimids are capable of hitting many more targets, including those previously thought to be undruggable, while reducing the potential for drug resistance. The broad applicability of Degronimids, and our chemical biology platform designed for accelerated validation, have the potential to make an unprecedented impact across many diseases through multiple industry collaborations as well as proprietary programs. The Company has received an exclusive worldwide license to the Degronimid platform and related IP from Dana-Farber.

ARRIS

Series B in 2020
ARRIS develops an additive molding technology for manufacturing 3D-aligned continuous fiber thermoplastic composite parts at scale. Its composites manufacturing technology combines continuously aligned fibers, electronics, and metallic components within topology-optimized structures.

Regenacy Pharmaceuticals

Series A in 2020
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.

LandingAI

Convertible Note in 2020
LandingAI empowers customers to harness the business value of AI by providing enablement tools and transformation programs. One of the company’s core products is LandingLens, an end-to-end AI platform specifically designed for industrial customers to build, deploy and scale AI-powered visual inspection solutions. Founded by one of the most recognizable names in AI, Dr. Andrew Ng, (founding lead of the Google Brain team and former Chief Scientist at Baidu), and a world class team, LandingAI is uniquely positioned to help companies across the globe successfully move their AI projects from proof-of-concept to full-scale production. Additional information is available at: www.landing.ai.

AEye

Convertible Note in 2020
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Korea, and the United States.

Metanoia Communications

Venture Round in 2020
Metanoia Communications (”Metanoia”) was established in Hsinchu Science Park, Taiwan in 2004. Metanoia develops semiconductor and software solutions to the Wireline broadband market and the in-home networking market, providing very high-speed PHY chipsets to the broadband manufacturers. Metanoia combines “state of the art” system architecture and algorithm expertise with extensive integrated circuit design capabilites to deliver a broad range of fixed line communication products for access and In-home applications. Their portfolio includes products for the xDSL markets (more specifically for the VDSL2 and the upcoming G.fast markets), and the G.hn market.

DSP Concepts, Inc.

Series B in 2020
DSP Concepts is the Silicon Valley based leader in the Audio of Things (AoT) market and the creator of Audio Weaver, the Audio Experience platform that makes audio innovation easy. DSP Concepts equips and supports engineers with real-time workflows to quickly stand up prototypes, collaborate and modify designs across teams, and deploy to the most popular chipsets from leading semiconductor companies including NXP, Qualcomm, STMicroelectronics, Cadence, Arm, and others. DSP Concepts technologies are embedded in millions of automotive and consumer products, delivering remarkable Audio Experience solutions to prestigious brands including Bang & Olufsen, BMW, Braun, Facebook, Garmin, GoPro, LG, Mercedes Benz, Panasonic, Peloton, Porsche, Samsung, Sennheiser, Spotify, Tesla, and many more.

Tripresso

Series A in 2020
Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Viracta Therapeutics

Series D in 2019
Viracta is a precision oncology company targeting virus-associated malignancies. Viracta's proprietary investigational drug, nanatinostat, is currently being evaluated in combination with the antiviral agent valganciclovir as an oral combination therapy in a Phase 2 clinical trial for EBV-positive lymphoma. Viracta is pursuing application of this inducible synthetic lethality approach in other EBV-associated malignancies, such as nasopharyngeal carcinoma, gastric carcinoma, and other virus-related cancers.
Pavilion Data Systems is redefining storage to put real-time performance at scale within reach of all. Pavilion provides unmatched storage performance and density, without the cost and complexity of legacy all flash arrays (AFAs). Pavilion provides consistent, predictable performance across the fabric with ultra-low latency and linear scalability. Pavilion has disrupted the enterprise storage landscape with its innovative architecture and software and is pulling the industry into a new category of storage appliances: Hyperparallel Flash Arrays. Hyperparallel Flash Arrays utilize multiple controllers within a single system and leverage the parallelism of flash to go beyond the limitations of legacy, dual controller AFAs, delivering breakthrough performance and value. Pavilion is the leader of this new “Third wave” of storage with the largest deployments and most deployments because the customer need for ever-increasing data throughput continues to expand. Pavilion Data Systems brings together experienced technology professionals with expertise in storage system architecture, network switch design, dense micro-server architectures, and solid-state storage technology to deliver a ground-breaking storage system design that is purpose-built to take advantage of memory-class media available both today and in the future.

Light Field Lab

Series A in 2019
Light Field Lab is a breakthrough technology startup that builds an innovative holographic ecosystem. It re-creates what optical physics calls a real image for off-screen projected objects by generating a massive number of viewing angles that correctly change with the point of view and location just like in the real world. They enable entirely new business opportunities across consumer and enterprise markets. The company was founded in 2017 by Jon Karafin, Brendan Bevensee, and Ed Ibe, with the single mission to enable a holographic future by building upon the founders’ collective expertise of light field technology innovation. Based in San Jose, CA, Light Field Lab is backed by top-tier venture firms including Khosla Ventures.

Frequency Therapeutics

Series C in 2019
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

Touché Solutions

Series A in 2019
Touché Solutions(formerly known as Mechavision), mainly manufactures robot sensor modules, and its developed plug-in robot haptic technology products have been used in Qisda's human-machine collaboration production line.

Ambiq Micro

Convertible Note in 2019
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low-power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.

Frequency Therapeutics

Series B in 2019
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

AEye

Series B in 2018
AEye’s unique software-defined lidar solution enables advanced driver-assistance, vehicle autonomy, smart infrastructure and logistics applications that save lives and propel the future of transportation and mobility. AEye’s 4Sight™ Intelligent Sensing Platform, with its adaptive sensor-based operating system, focuses on what matters most: delivering faster, more accurate, and reliable information. AEye’s 4Sight™ products, built on this platform, are ideal for dynamic applications which require precise measurement imaging to ensure safety and performance. AEye has a global presence through its offices in Germany, Korea, and the United States.

Cognito Health

Series A in 2018
Cognito Health improves the healthcare environment by increasing value for patients and healthcare systems. They continuously monitor patients using predictive algorithms to inform their staff about potential bed exits and repositioning needs.

Ambiq Micro

Series E in 2018
Ambiq Micro is an early-stage fabless semiconductor company that is developing ultra-low-power mixed-signal solutions for a new generation of wireless electronics. Ambiq Micro was founded in 2010 on the simple yet powerful notion that extremely low-power semiconductors are the key to the future of electronics. Through the use of their pioneering ultra-low-power technology, they help innovative companies around the world develop differentiated solutions that reduce or eliminate the need for batteries, lower overall system power, and maximize industrial design flexibility.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.